AIDS by Oster, Alexandra M.
The Evolving Contribution of Emergency Department Testing 
Studies: From Risk to Care
Alexandra M. Oster, MD
Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention Centers for Disease Control and Prevention
This issue of AIDS includes data from HIV serosurveys conducted in the Johns Hopkins 
Emergency Department (ED) over nearly 3 decades, including data from 2013 that have not 
previously been published (ref Kelen 2015). The earliest of the serosurveys, conducted in 
1986 and 1987, aimed to document prevalence of HIV infection, with an eye toward 
quantifying occupational risk for health care providers [1, 2]. These early studies 
demonstrated the need for universal infection control precautions. A follow-up study in 1988 
aimed to identify trends in HIV prevalence, document adherence to universal precautions 
implemented in the interim, and assess the burden of HIV-related service use in an 
emergency setting [3]. Together, these early serosurveys painted a picture of the 
epidemiology of HIV in an inner-city ED, examining the associations of demographic, risk, 
and geographic factors with HIV infection. They have also been important in understanding 
clinical presentations and courses for those patients with both known and unrecognized HIV 
infection in emergency settings.
Over time, the Johns Hopkins ED-based surveys also documented the emergence of HIV 
among populations not previously documented to be at risk, such as persons with 
heterosexual risk [4]. Additionally, the focus of the studies began to shift toward assessing 
feasibility of ED testing and identifying factors that could be used to prioritize groups for 
testing in ED settings [4]. Soon after, in 1993–1995, the Johns Hopkins ED instituted a 
routine HIV testing program. Since that time, many other EDs have followed suit, 
contributing to our understanding of the picture of HIV in diverse settings across the country 
[5].
Recently, with a study conducted during 2007, the Johns Hopkins group explored the HIV 
care continuum for HIV-infected patients encountered in the ED [6]. That work has been 
extended in the current publication, which describes the HIV care continuum for patients 
encountered in the Johns Hopkins ED during 2013 in the context of data from the previous 
studies dating from 1987 to 2007 (ref Kelen 2015). The study, which includes data on a 
variety of measures, including HIV prevalence, incidence, proportion undiagnosed, linkage 
to HIV care, antiretroviral use, and viral suppression, provides a detailed picture of how the 
role of the Johns Hopkins ED has changed through the years.
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It is worth noting that the Johns Hopkins HIV testing studies have some important 
limitations – the results can only be extrapolated to persons who visit the ED, and there are 
limitations with respect to ability to deduplicate records for persons with multiple ED visits 
during the study period. Additionally, the data are not comprehensive – they do not capture 
care received elsewhere. Ultimately, generalizable data regarding the HIV care continuum 
for HIV-infected persons in the United States are best sought through analyses of HIV 
surveillance data, including those from the National HIV Surveillance System and the 
Medical Monitoring Project [7, 8].
Still, ED studies have provided a snapshot of HIV care for a subset of urban, underserved 
persons living with HIV infection in a particular geographic area. In a sense, the ED-based 
studies represent a microcosm of the evolution of HIV prevention. In the 1980s, little was 
known and there was fear among both health care providers and the general public that they 
might be at risk of acquiring HIV. As time passed and treatments improved, HIV prevention 
shifted toward testing and awareness of infection. With these most recent manuscripts, the 
Johns Hopkins ED testing program has shifted focus, in tandem with the goals of the 
National HIV/AIDS Strategy,1 to focus on care and reducing onward transmission.
This type of unlinked anonymous serosurvey played an important role for surveillance in the 
early HIV epidemic, when not all states required reporting of HIV infection and, therefore, 
data on prevalence were not widely available. However, since that time, surveillance data 
have improved dramatically and treatment has become available, with the benefits to both 
individual and public health ever more well-documented. Although all of the Johns Hopkins 
serosurveys were approved by the Johns Hopkins University School of Medicine 
Institutional Review Board, many have argued that unlinked HIV serosurveys, which do not 
provide results back to the individuals tested, are no longer ethical [9]. The Centers for 
Disease Control and Prevention ceased conducting unlinked serosurveys within the United 
States in the mid-1990s, and their use in global settings has become increasingly 
unsupported.
For more than 25 years, the Johns Hopkins ED HIV testing studies have helped us to 
understand the burden of HIV in inner-city Baltimore. The Johns Hopkins ED HIV testing 
program has served as a model for other ED HIV testing programs. Although the time has 
likely come to dispense with unlinked serosurveys, it can be expected that we will continue 
to learn from the experiences of the Johns Hopkins ED routine testing programs for many 
years to come.
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